首页> 外文期刊>Clinical oncology >Granulocyte Colony-stimulating Factor-producing Upper Urinary Tract Carcinoma: Systematic Review of 46 Cases Reported in Japan
【24h】

Granulocyte Colony-stimulating Factor-producing Upper Urinary Tract Carcinoma: Systematic Review of 46 Cases Reported in Japan

机译:产生粒细胞集落刺激因子的上尿路癌:日本报道的46例系统评价

获取原文
获取原文并翻译 | 示例
       

摘要

Aims: Granulocyte colony-stimulating factor (G-CSF)-producing upper urinary tract carcinoma is extremely rare, and we do not yet have a comprehensive understanding of the disease. This study was carried out to determine the characteristics of G-CSF-producing upper urinary tract carcinoma. Materials and methods: A systematic MEDLINE and ICHUSHI WEB (Japan Medical Abstract Society) search was carried out to identify articles and conference proceedings describing patients with G-CSF-producing upper urinary tract carcinoma. The final cohort included 46 patients: eight studies were published in English, 16 in Japanese and there were 18 Japanese conference proceedings. Results: The average age of patients was 67 years and the male to female ratio was 2.5 to 1. The mean white blood cell count was as high as 33 900/μl (range 10 000-121 000) in these patients. Pretreatment serum G-CSF levels were measured in 23 patients, all of which were higher (range 55-1220pg/ml) than normal levels. Metastasis was detected in 29 patients (63%) and lymph node and lung metastases were well observed. The most commonly reported primary treatment was surgery (33 patients), but the median survival period for these patients was short (4.5 months). Multivariate analysis showed that lymph node and/or distant metastasis (hazard ratio 2.92, P=0.020) and the absence of adjuvant therapy (hazard ratio 3.20, P=0.014) were independent risk factors for mortality. A total of only seven patients survived more than 1 year and most had a history of neoadjuvant/adjuvant chemotherapy and/or radiation therapy. Conclusion: We believe that the presence of G-CSF-induced leukocytosis represents a distinct and highly aggressive form of upper urinary tract carcinoma. However, the results of our systematic review indicate that a multidisciplinary approach including surgery, neoadjuvant or adjuvant chemotherapy and radiotherapy may have the potential to control the disease, although we cannot provide definitive recommendations from this retrospective study.
机译:目的:产生粒细胞集落刺激因子(G-CSF)的上尿路癌极为罕见,我们对该病尚无全面了解。进行了这项研究以确定生产G-CSF的上尿路癌的特征。材料和方法:进行了系统的MEDLINE和ICHUSHI WEB(日本医学摘要学会)搜索,以鉴定描述产生G-CSF的上尿路癌患者的文章和会议记录。最后的队列包括46名患者:8项研究用英文发表,16项用日语发表,有18项日本会议记录。结果:患者的平均年龄为67岁,男女之比为2.5:1。这些患者的平均白细胞计数高达33 900 /μl(范围10000-121 000)。测量了23名患者的治疗前血清G-CSF水平,所有这些水平均高于正常水平(55-1220pg / ml)。 29例患者(63%)检测到转移,并且淋巴结转移和肺转移良好。最常报告的主要治疗方法是手术(33例患者),但这些患者的中位生存期较短(4.5个月)。多因素分析表明,淋巴结转移和/或远处转移(危险比2.92,P = 0.020)和缺乏辅助治疗(危险比3.20,P = 0.014)是导致死亡的独立危险因素。总共只有7名患者存活超过1年,并且大多数有新辅助/辅助化疗和/或放疗的病史。结论:我们认为,G-CSF诱导的白细胞增多症代表了上尿路癌的一种独特且高度侵袭性的形式。然而,我们的系统评价结果表明,尽管我们无法从这项回顾性研究中提供明确的建议,但包括外科手术,新辅助或辅助化疗以及放疗在内的多学科方法可能具有控制疾病的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号